Endothelial dysfunction (ED) in patients with autosomal dominant polycystic kidney disease (ADPKD)

被引：0
|
作者：
Kocaman, O [1 ]
Oflaz, H [1 ]
Genchellac, H [1 ]
Ungor, S [1 ]
Kazancioglu, R [1 ]
Ozsaruhan, O [1 ]
Ecder, T [1 ]
机构：
[1] Istanbul Sch Med, Istanbul, Turkey
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：507A / 507A
页数：1
相关论文
共 50 条
  • [21] Ambulatory blood pressure and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease
    Turgut, Faruk
    Oflaz, Hueseyin
    Namli, Sule
    Alisir, Sabahat
    Tufan, Fatih
    Temiz, Suleyman
    Umman, Sabahattin
    Ecder, Tevfik
    RENAL FAILURE, 2007, 29 (08) : 979 - 984
  • [22] Autosomal dominant polycystic kidney disease: modifier genes and endothelial dysfunction
    Devuyst, O
    Persu, A
    Vo-Cong, MT
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (11) : 2211 - 2215
  • [23] UTILIZATION OF RADIOGRAPHIC IMAGING IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Sanon, Myrlene
    Stellhorn, Robert
    Pao, Christina
    Seliger, Stephen
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 729 - 729
  • [24] Hypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease
    Theodorakopoulou, Marieta
    Raptis, Vasileios
    Loutradis, Charalampos
    Sarafidis, Pantelis
    SEMINARS IN NEPHROLOGY, 2019, 39 (06) : 599 - 612
  • [25] Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Norman, Jill
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (10): : 1327 - 1336
  • [26] EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PRESENTS WITH ENDOTHELIAL DYSFUNCTION THAT PRECEDES HEMODYNAMIC CHANGES AND CORRELATE WITH DISEASE SEVERITY
    Kahveci, Ali
    Eirin, Alfonso
    Lerman, Lilach O.
    Torres, Vicente
    Irazabal, Maria V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (04) : 859 - 860
  • [27] A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
    Phil McEwan
    Hayley Bennett Wilton
    Albert C. M. Ong
    Bjarne Ørskov
    Richard Sandford
    Francesco Scolari
    Maria-Cristina V. Cabrera
    Gerd Walz
    Karl O’Reilly
    Paul Robinson
    BMC Nephrology, 19
  • [28] Vascular endothelial growth factor (VEGF) Isoforms in autosomal dominant polycystic kidney disease (ADPKD).
    Tao, YX
    Jun, K
    Schrier, RW
    Edelstein, CL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 582A - 582A
  • [29] A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
    McEwan, Phil
    Wilton, Hayley Bennett
    Ong, Albert C. M.
    Orskov, Bjarne
    Sandford, Richard
    Scolari, Francesco
    Cabrera, Maria-Cristina V.
    Walz, Gerd
    O'Reilly, Karl
    Robinson, Paul
    BMC NEPHROLOGY, 2018, 19
  • [30] Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD
    Dana Rizk
    Arlene Chapman
    Pediatric Nephrology, 2008, 23 : 1029 - 1036
12345